SCHEMBL4154186

SCHEMBL4154186

CN(C(=O)Cl)c1ccc(SC(F)(F)F)cc1F

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 1/20 0.37
MAPT P10636 1/20 0.37
TSHR P16473 1/20 0.37
MAPK1 P28482 1/20 0.37
HTT P42858 1/20 0.37
KCNK2 O95069 5/20 0.33
KCNK10 P57789 4/20 0.33
FSCN1 Q16658 1/20 0.33
KIF11 P52732 1/20 0.33
TRPV1 Q8NER1 1/20 0.33
PDK2 Q15119 2/20 0.33
SMN1; SMN2 Q16637 2/20 0.33
NPC1 O15118 1/20 0.33
RAB9A P51151 1/20 0.33
PTPRZ1 P23471 1/20 0.33
ALDH1A1 P00352 2/20 0.33
KDM4E B2RXH2 1/20 0.33
TDP1 Q9NUW8 1/20 0.33
PDE2A O00408 1/20 0.32
EPHX2 P34913 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3618932 0.87 FSCN1 (0.44) LMNAMAPTTSHRMAPK1HTT
SCHEMBL4149723 0.83 TSHR (0.38) LMNAMAPTTSHRMAPK1HTT
SCHEMBL14819986 0.83 TSHR (0.35) LMNAMAPTTSHRMAPK1HTT
SCHEMBL4142460 0.82 LMNA (0.35) LMNAMAPTTSHRMAPK1HTT
SCHEMBL4158539 0.80 MAPT (0.36) LMNAMAPTTSHRMAPK1HTT
SCHEMBL4142022 0.80 PTPRZ1 (0.37) LMNAMAPTTSHRMAPK1HTT
SCHEMBL4150851 0.79 PTPRZ1 (0.36) LMNAMAPTTSHRMAPK1HTT
SCHEMBL4154041 0.78 EPHX2 (0.39) LMNAMAPTTSHRMAPK1HTT
SCHEMBL4149940 0.77 PTPRZ1 (0.35) LMNAMAPTTSHRMAPK1HTT
SCHEMBL4154435 0.77 RORC (0.36) LMNAMAPTTSHRMAPK1HTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090176786-A1 Benzoylurea Compounds and Use Thereof SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2009-07-09 US disclosed
US-20090176786-A1 Benzoylurea Compounds and Use Thereof SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2009-07-09 US disclosed
US-20090176786-A1 Benzoylurea Compounds and Use Thereof SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2009-07-09 US disclosed
EP-1937629-A2 BENZOYLUREA COMPOUNDS AND USE THEREOF Sumitomo Chemical Company, Limited (JP) 2008-07-02 EP disclosed
WO-2007046513-A2 BENZOYLUREA COMPOUNDS AND USE THEREOF SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2007-04-26 WO disclosed
WO-2007046513-A2 BENZOYLUREA COMPOUNDS AND USE THEREOF SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2007-04-26 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090176786-A1 Benzoylurea Compounds and Use Thereof BTK, BRIX1, NFXL1 LMNA 2141/4885MAPT 4585/4885TSHR 332/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.